SCHEMBL6982374

SCHEMBL6982374

CCCCCCc1cccnc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 9/20 0.47
LIPG Q9Y5X9 1/20 0.47
BACE1 P56817 1/20 0.46
TLR7 Q9NYK1 2/20 0.44
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KCNH2 Q12809 1/20 0.43
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
DHFR P00374 1/20 0.41
BID P55957 2/20 0.41
BCL2L1 Q07817 2/20 0.41
MCL1 Q07820 2/20 0.41
BAK1 Q16611 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27725467 1.00 TLR8 (0.47) TLR8LIPGBACE1TLR7TDP1
SCHEMBL28020387 1.00 TLR8 (0.47) TLR8LIPGBACE1TLR7TDP1
SCHEMBL11401202 1.00 TLR8 (0.47) TLR8LIPGBACE1TLR7TDP1
Hydrochloric Acid SCHEMBL8582822 0.98 TLR8 (0.46) TLR8LIPGBACE1TLR7TDP1
SCHEMBL750976 0.98 TLR8 (0.49) TLR8LIPGBACE1TLR7TDP1
SCHEMBL8049756 0.93 BACE1 (0.49) TLR8LIPGBACE1TLR7TDP1
SCHEMBL28906708 0.91 TLR8 (0.42) TLR8LIPGBACE1TLR7NOS1
SCHEMBL2384178 0.85 BACE1 (0.51) TLR8BACE1TDP1NOS3NOS1
SCHEMBL31420504 0.82 BACE1 (0.46) BACE1TLR7NOS3NOS1NOS2
SCHEMBL8720799 0.81 LIPG (0.50) LIPGTDP1L3MBTL1KCNH2BID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4305031-A1 7-MORPHOLINO-L,6-NAPHTHYRIDIN-5-YL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS DNA-PK INHIBITOR Admare Therapeutics Society (CA) 2024-01-17 EP disclosed
CN-1854128-A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INST TECHNOLOGY (US) 2006-11-01 CN disclosed
CN-1266112-C Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation MASSACHUSETTS INST TECHNOLOGY (US) 2006-07-26 CN disclosed
CN-1518534-A Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation 麻省理工学院 2004-08-04 CN disclosed
EP-1311507-A1 FUSED PYRAZOLE DERIVATIVES BEING PROTEIN KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2003-05-21 EP disclosed
WO-2002016359-A1 FUSED PYRAZOLE DERIVATIVES BEING PROTEIN KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2002-02-28 WO disclosed
EP-0120589-B1 IMIDAZO-HETEROCYCLIC COMPOUNDS, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-08 EP disclosed
US-4621084-A CARDIOTONIC, ANTIULCER FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-11-04 US disclosed
EP-0120589-A1 Imidazo-heterocyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-03 EP disclosed